To access this element change to forms mode OFF
Grant Award View - GA203600
Rapid evolution of a genome editing tool
GA ID:
GA203600
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
1-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$650,740.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Rapid evolution of a genome editing tool
Purpose:
CRISPR–Cas9 is a powerful DNA targeting tool for genome editing and gene therapy. While the tool already shows promising results, its accuracy is not good enough for use in treatment of patients. I aim to develop a novel, high-throughput directed-evolution tool to improve the accuracy and specificity of Cas9 enzymes. The Cas9 with improved specificity will allow the wider and more reliable use of CRISPR technology in medical applications.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2007778
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Wollongong
Recipient ABN:
61 060 567 686
Grant Recipient Location
Suburb:
Wollongong
Town/City:
Wollongong
Postcode:
2500
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA